eTheRNA immunotherapies Revenue and Competitors
Estimated Revenue & Valuation
- eTheRNA immunotherapies's estimated annual revenue is currently $19.1M per year.
- eTheRNA immunotherapies's estimated revenue per employee is $155,000
Employee Data
- eTheRNA immunotherapies has 123 Employees.
- eTheRNA immunotherapies grew their employee count by 3% last year.
eTheRNA immunotherapies's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | VP Product Development | Reveal Email/Phone |
3 | VP Human Resources | Reveal Email/Phone |
4 | Director, Business Development (CMO) | Reveal Email/Phone |
5 | Chief Business Officer | Reveal Email/Phone |
6 | QC Manager | Reveal Email/Phone |
7 | QA Engineer | Reveal Email/Phone |
8 | Equipment & Stock Management Coordinator | Reveal Email/Phone |
9 | Back-up aseptic production associate | Reveal Email/Phone |
10 | Principal Scientist Immuno-Oncology / Group leader immunomodulation Therapies | Reveal Email/Phone |
eTheRNA immunotherapies Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $99.4M | 458 | 40% | N/A | N/A |
#2 | $20.6M | 133 | 22% | N/A | N/A |
#3 | $156.1M | 146 | -70% | $145M | N/A |
#4 | $3.5M | 45 | -25% | $150M | N/A |
#5 | $1.6M | 21 | 0% | $459.5M | N/A |
#6 | $67.3M | 310 | 16% | $180.7M | N/A |
#7 | $8.5M | 55 | -2% | N/A | N/A |
#8 | $256.3M | 1025 | 9% | $168.5M | N/A |
#9 | $2.8M | 18 | -33% | N/A | N/A |
#10 | $9.1M | 59 | -9% | N/A | N/A |
What Is eTheRNA immunotherapies?
eTheRNA is developing innovative immuno-oncology therapies based on its unique APC-activating messenger RNA platform.
keywords:N/A
N/A
Total Funding
123
Number of Employees
$19.1M
Revenue (est)
3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
eTheRNA immunotherapies News
2022-04-19 - mRNA Vaccine Market Size, Scope And Forecast | Argos ...
Argos Therapeutics BioNTech AG, CureVac AG, eTheRNA Immunotherapies, Ethris GmbH, Incellart, Moderna Sangamo Therapeutics Tiba Biotech,...
2022-04-06 - eTheRNA Announces Relocation and Expansion of R&D Facility
GENT, Belgium, April 05, 2022 (GLOBE NEWSWIRE) -- eTheRNA immunotherapies NV (eTheRNA), an mRNA technology discovery and development...
2022-03-22 - eTheRNA Manufacturing Announces New LNP Formulation ...
This new LNP service uses eTheRNA's proprietary lipid libraries and ... eTheRNA immunotherapies NV, we can also provide support in stability...
Other Companies in Niel
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $29M | 132 | 12% | N/A |
#2 | $48.3M | 144 | 12% | N/A |
#3 | $178.2M | 679 | 24% | N/A |
#4 | $307.9M | 1094 | -12% | N/A |